Agenda

Agenda

All times are in Japan Local Time.
Program is subject to change.

Updated based on the program summary dated July 7, 2026.

Short Course Day 1 (Sat Nov 21, 2026)

Time Session Location People
8:30-9:00 AM Registration / Breakfast TBD
9:00 AM-12:00 PM TBD TBD TBD
9:00 AM-5:00 PM TBD TBD TBD
12:00-1:00 PM Lunch TBD
1:00-5:00 PM TBD TBD TBD
1:00-5:00 PM TBD TBD TBD

Conference Program Day 2 (Sun Nov 22, 2026)

Time Session Location People
8:30-9:00 AM Registration and Breakfast TBD
9:00-9:10 AM Opening Remark TBD Yuan Ji, PhD, UChicago
Satoshi Hattori, PhD, Osaka
9:10-10:00 AM Keynote Session 1: Oncology Keynote TBD Speaker: Kan Yonemori, MD, PhD, NCCH
Moderator: Shivaani Kummar, MD, OHSU
10:00-10:15 AM Break (Poster Session 1) TBD
10:15-11:45 AM Invited Session 1: Advancing platform trials in oncology TBD
10:15-11:45 AM Invited Session 2: Treatment switching in oncology trials TBD
11:45 AM-12:45 PM Lunch (Poster Session 1) TBD
12:45-1:35 PM Keynote Session 2: Clinical Trial Keynote TBD Speaker: Marc Buyse, ScD, University of Hasselt
Moderator: Susan Halabi, PhD, Duke
1:35-1:50 PM Break (Poster Session 1) TBD
1:50-3:20 PM Plenary Session 1: Panel discussion on modern statistical frameworks for pediatric oncology and rare disease clinical trials TBD Organizers: Haitao Pan, PhD, St. Jude; Yuan Ji, PhD, UChicago
Panelists: Elizabeth Fox, MD, St. Jude; Kentaro Takeda, PhD, Astellas; Vicky Qian Wu, PhD, Fred Hutch; Luyan Dai, PhD, G-Plume Group
3:20-3:35 PM Break (Poster Session 1) TBD
3:35-5:05 PM Invited Session 3: Dose optimization TBD
3:35-5:05 PM Invited Session 4: Data science in oncology: from data to clinical impact TBD Proposer: Chao Agnes Hsiung, PhD, NHRI
Moderator: TBD
Speakers: Takashi Kohno, PhD, NCC Japan; Kouya Shiraishi, PhD, NCCRI; I-Shou Chang, PhD, NHRI; Chao-Hua Chiu, MD, PhD, TMUH
5:05-5:45 PM Break (Poster Session 1) TBD
5:45-8:45 PM Banquet TBD

Conference Program Day 3 (Mon Nov 23, 2026)

Time Session Location People
8:30-9:00 AM Registration and Breakfast TBD
9:00-9:50 AM Keynote Session 3: Bioinformatics/AI Keynote TBD Speaker: Hongyu Zhao, PhD, Yale
Moderator: Shannon McWeeney, PhD, OU
9:50-10:05 AM Break (Poster Session 2) TBD
10:05-11:35 AM Invited Session 5: Emerging trends in oncology drug development - regulatory, statistical, and clinical perspectives TBD Moderator: Toshimitsu Hamasaki, PhD, GWU
Speakers: Toyotake Iguchi, MD, PhD, NHRI; Tzy-Chy Lin, MD, PhD, Taiwan CDE; Shunsuke Shiota, MMS, PMDA; Kenichi Nakamura, MD, PhD, NCC Japan
10:05-11:35 AM Invited Session 6: From data to evidence - statistical learning and AI methods for oncology trials TBD Moderator: Wei Wei, PhD, Yale
Speakers: Ruitao Lin, PhD, MD Anderson; Shouhao Zhou, PhD, Penn State; Yanxun Xu, PhD, JHU; Arsela Prelaj, MD, ESMO; Ravi Parikh, MD, Emory
11:35 AM-12:35 PM Lunch (Poster Session 2) TBD
12:35-1:25 PM Keynote Session 4: Regulatory Keynote TBD Speaker: Yasuhiro Fujiwara, MD, PhD, PMDA
Moderator: Hajime Uno, PhD, Harvard
1:25-1:40 PM Break (Poster Session 2) TBD
1:40-3:10 PM Invited Session 7: Development of AI-powered prognostic and predictive biomarkers to guide treatment TBD
1:40-3:10 PM Invited Session 8: Rapid talks TBD Moderator: Byung Park, PhD, OHSU
Reserved for sponsors and poster winners
3:10-3:25 PM Break (Poster Session 2) TBD
3:25-4:50 PM Plenary Session 2: Panel discussion on new regulatory guidelines on RWD, rare disease, biomarker, and Bayesian statistical methods TBD
4:50-5:00 PM Closing Remarks TBD

Short Course Day 4 (Tue Nov 24, 2026)

Time Session Location People
8:30-9:00 AM Registration / Breakfast TBD
9:00 AM-5:00 PM TBD TBD TBD
9:00 AM-5:00 PM TBD TBD TBD
12:00-1:00 PM Lunch for all courses TBD